Summit Therapeutics (SMMT) Enterprise Value (2015 - 2026)
Summit Therapeutics' Enterprise Value was $12.89 billion in Q3 2026, down 14.8% from $15.14 billion a year earlier but up 18.7% from the prior quarter.
Summit Therapeutics (SMMT) Enterprise Value (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Summit Therapeutics' Enterprise Value was $10.89 billion through Sep 30, 2026, down 22.6% year-over-year; for FY2025, it was $12.85 billion, up 0.8% from FY2024.
- Enterprise Value has now increased for four consecutive years, with a five-year compound annual growth rate of 109.1% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $12.75 billion in FY2024 (+674.8%), $1.65 billion in FY2023 (+199.9%), $548.53 million in FY2022 (+185.8%) and $191.94 million in FY2021 (-40.3%).
- Quarterly Enterprise Value has moved between $54.84 million (Q3 2022) and $15.66 billion (Q3 2024) over five years.
- Compared with a year earlier, Enterprise Value was higher in five of the last eight quarters, with growth averaging 153.4%.
- The best year-over-year quarter for Enterprise Value over five years was Q4 2024 (growth of 674.8%); the worst was Q3 2022 (a decline of 88.8%).
- Per Business Quant data, SMMT's Enterprise Value in the three quarters before Q3 2026 was $10.87 billion (Q2 2026), $14.11 billion (Q1 2026) and $12.85 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Summit Therapeutics | 14.26 Bn | 11.63 Bn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.89 Bn |
| Jun 30, 2026 | 10.87 Bn |
| Mar 31, 2026 | 14.11 Bn |
| Dec 31, 2025 | 12.85 Bn |
| Sep 30, 2025 | 15.14 Bn |
| Jun 30, 2025 | 15.51 Bn |
| Mar 31, 2025 | 13.94 Bn |
| Dec 31, 2024 | 12.75 Bn |
| Sep 30, 2024 | 15.66 Bn |
| Jun 30, 2024 | 5.32 Bn |
| Mar 31, 2024 | 2.75 Bn |
| Dec 31, 2023 | 1.65 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.54 Bn |
| Mar 31, 2023 | 419.85 Mn |
| Dec 31, 2022 | 548.53 Mn |
| Sep 30, 2022 | 54.84 Mn |
| Jun 30, 2022 | 40.79 Mn |
| Mar 31, 2022 | 162.95 Mn |
| Dec 31, 2021 | 191.94 Mn |
Summit Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=SMMT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();